News

The company filed a new drug application to the Ministry of Health, Labor and Welfare in Japan for TA-7284 to treat patients with type 2 diabetes. The efficacy

The application was filed by Astellas with the Ministry of Health, Labour and Welfare in Japan. Oral androgen receptor inhibitor enzalutamide is designed to inhibit multiple steps in

The application of its zinc finger nuclease (ZFN) gene-editing technology in hematopoietic stem cells (HSCs) will be leveraged in the development of potentially curative ZFP Therapeutic. Funds required

Launch of the new application, especially for mothers, was based on a survey that noted more than half of parents were worried of incorrectly identifying their child’s symptoms

Novo chief scientific officer Mads Thomsen was quoted by health24.com as saying that liraglutide treatment was likely to be launched in the US at the end of next

Postmenopausal women with locally advanced or metastatic estrogen receptor positive (ER+) and/or progesterone receptor positive (PR+), HER2-negative breast cancer are participating in the randomized, double blind trial. Merrimack

As per terms of the deal, BTG is expected to gain TheraSphere, which is the sole targeted liver cancer therapy product of Targeted Therapies business that is manufactured

A total of 120 individuals are expected to be included in the double-blind, multicenter study designed to assess the safety and efficacy profile of UC1010. Umecrine Mood CEO

The application covers the use of Abraxane and gemcitabine combination therapy for the front line treatment of patients with advanced pancreatic cancer. In April 2013, the European Medicines